DB05652ExperimentalSmall molecule
VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications. It is being...
- Primary indication
- Investigated for use/treatment in psoriasis and psoriatic disorders.Curator reviewed
- Code names
- VTP-201227
Which companies are running trials of VTP-201227, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account